Hypoglycemia risk is low in individuals without diabetes not taking other glucose-lowering medications
Beyond weight loss, early exploratory data suggest potential benefits including: Reductions in HbA1c (a marker of blood sugar control) in people with type 2 diabetes Improvements in lipid profiles (cholesterol and triglycerides) Reductions in liver fat, which may be relevant for metabolic dysfunction-associated steatotic liver disease (MASLD, formerly NAFLD), though these findings are preliminary Possible cardiovascular benefits
Colchicine is one of a small number of drugs where new studies were done (for example, of drug interactions and re-evaluation of dosing) where the FDA has granted brand status to a manufacturer despite the unbranded form having long been available
Hayat S, Hayat Q, Alyemeni MN et al (2012) Role of proline under changing environments: a review
BPC-157 has a documented role in gut protection and mucosal healing that goes back to its original discovery as a fragment of gastric juice protein
Try Gluta Glow Safe oral alternative Frequently asked questions Did CDSCO actually ban glutathione injections
